Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry


PRINCETON, N.J. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Apr 4, 2024–

Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, announces the launch of My Mental Health Journey, a longitudinal registry study that aims to advance research in depression and mental health. Verily Life Sciences LLC (Verily), a precision health technology company, will recruit participants and run the study.

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.


Leave a Reply

Your email address will not be published. Required fields are marked *